IHS Chemical Week

Archives :: Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Displaying 341 - 352 of 1421 stories.
July 1, 2014
Feature FDA tightens control over India’s API manufacturers FDA has, since 2013, issued warning letters to several active pharmaceutical ingredient (API) manufacturing facilities...
June 24, 2014
FDA issues warning letters to API plants in China and India FDA issued separate warning letters earlier this month to the active pharmaceutical ingredient (API) manufacturing...
June 18, 2014
FDA issued separate warning letters earlier this month to the active pharmaceutical ingredient (API) manufacturing facilities of Tianjin Zhongan Pharmaceutical (Tianjin, China) and...
June 18, 2014
Merck Millipore, the life sciences tools division of Merck KGaA, today opened a new process solutions formulation laboratory in India, its first outside Europe. The lab, which is part...
June 17, 2014
Aqualis (Oslo) announced on 17 June that it has entered into a definitive share purchase agreement with Weifa Holding to acquire all of the shares in Weifa (Oslo), a leading...
June 17, 2014
Merck KGaA announced today that it has reached a mutual agreement with Ono Pharmaceutical (Osaka) to terminate a license agreement for ceralifimod (ONO-4641) because it does not meet...
June 17, 2014
Lonza invests in single-use technology and facility upgrades for clinical ADC manufacturing Lonza says it is investing in technology and facility improvements to its antibody drug...
June 12, 2014
Meiji Holdings (Tokyo), through its Meiji Seika Pharma subsidiary, has agreed to acquire Bangalore, India based Medreich Ltd. Meiji agreed to pay $290 million for Medreich, which in...
June 10, 2014
Johnson Matthey's fine chemicals business reports rise in sales Johnson Matthey's (London) fine chemicals business reports a 7.5% rise in sales for the company’s fiscal year...
June 9, 2014
Merck said today that it has entered into a definitive agreement to acquire of biopharmaceuticals company Idenix Pharmaceuticals (Cambridge, MA) for $24.50/share in cash. The boards of...
June 9, 2014
ScinoPharm (Tainan, Taiwan), a company that develops and manufactures active pharmaceutical ingredients (APIs), says that it has signed a manufacturing contract with TaiGen...
June 5, 2014
After assessing of Ranbaxy Laboratories' (Gurgaon, India) active pharmaceutical ingredient (API) manufacturing facility at Toansa, India, European regulatory authorities say...
Pages: « Previous  26 27 28 29 30 31 32 33 34 [35] 36 37 38 39 40 41 42 43 44 Next »




RSS Follow us on Twitter Join us on LinkedIn Like us on Facebook Youtube channel
contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa